Mercury, NVIDIA deliver advanced visualization technology

TriMed Staff | | Health Imaging | Screening
Mercury Computer Systems Inc. and NVIDIA Corp. have entered a joint agreement to develop and deliver image processing technologies for the life sciences and geosciences markets.

Mercury and NVIDIA said they have developed and will deliver a robust set of offerings based on the NVIDIA Quadro graphics processors, Mercury's family of imaging software products, and new hardware platforms that leverage the full power of multiple GPUs for imaging applications. The complementary technologies are designed to provide advances in 3D image processing and visualization that reach beyond the current applications of interactive experience in the realm of life sciences, geosciences, biotechnology and simulation, the companies said.

TriMed Staff

Related Content

Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.